financetom
Business
financetom
/
Business
/
EU medicines regulator rejects Eisai-Biogen Alzheimer's drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU medicines regulator rejects Eisai-Biogen Alzheimer's drug
Jul 26, 2024 4:01 AM

July 26 (Reuters) - The European Union's drugs regulator

on Friday rejected Eisai ( ESALF ) and Biogen's

breakthrough treatment for early Alzheimer's disease, in a blow

to the drugmakers as take-up in the United States has been

slower than expected.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved